bf/NASDAQ:EWTX_icon.png

COM:EDGEWISETX

Edgewise Therapeutics

  • Stock

USD

Last Close

31.98

22/11 21:00

Market Cap

2.01B

Beta: -

Volume Today

352.86K

Avg: -

  • name

    Edgewise Therapeutics, Inc.
  • homepage url

    www.edgewisetx.com
  • country

    USUnited States
  • employee count

    92
  • sector

    Healthcare
  • industry

    Biotechnology

Description

Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. The Company's lead product candidate, EDG-5506, is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy which has completed Phase 1 clinical trial. ...Show More

peer of

investor of